Skip to main content
. Author manuscript; available in PMC: 2013 May 19.
Published in final edited form as: Crit Care Med. 2011 Dec;39(12):2711–2721. doi: 10.1097/CCM.0b013e3182284a5f

Figure 8. Amifostine pretreatment increases SOD activity in human pulmonary endothelial cells.

Figure 8

HPAEC were pretreated with vehicle (PBS) or amifostine for 3 days followed by 18% CS with or without thrombin challenge. Control cells were left under static conditions. Measurements of SOD activity were performed in control and stimulated cells. Data are presented as mean ± SD; n=3 for each group; *p<0.05; ***p<0.001.